MD, PhD FEBU Consultant Urologic Surgeon Urology Group Aalst AZORG Aalst, Belgium
Joined February 2019
- Tweets59
- Following181
- Followers158
- Likes119
Privileged to have been invited by #ERUS26 for a live nerve-sparing RARP surgery in Bologna.
Many thanks to Prof. Schiavina and his team for the warm welcome and outstanding support at Policlinico di Sant’Orsola.
🇮🇹🤝🇧🇪
#ERUS26 #LiveSurgery #RoboticSurgery #ProstateCancer
Edward Lambert retweeted
Urology Group Aalst Team Makes a Prominent Appearance at ERUS26 🇮🇹
From September 9 to 11, the international robotic urology community will gather in Padua for ERUS26, the 23rd annual meeting of the EAU Robotic Urology Section. The conference is known for its strong focus on live surgery, complex procedures, and the exchange of expertise among international specialists.
No fewer than four urologists from Urology Group Aalst are actively participating in the program:
- Prof. Alexandre Mottrie will perform a robot-assisted adrenalectomy using the Hugo robot.
- Dr. Edward Lambert will perform a robot-assisted radical prostatectomy using the Hugo robot.
- Dr. Ruben De Groote is performing a ureteral reimplantation using the Boari flap technique with the Hugo robot.
- Dr. Geert De Naeyer is supervising a teleproctoring case from Padua. He is remotely monitoring and guiding a procedure on a patient at the AZORG Moorselbaan campus. The adenomectomy is being performed using the TUMAI robot by a physician on site.
- Dr. De Backer will moderate several different lectures throughout the program.
“For us, robotic surgery is not just about technology, but above all about what we can do for patients with it. We want to perform complex procedures at a high level and share our knowledge with colleagues worldwide” says Dr. Ruben De Groote, urologist at AZORG.
With four AZORG urologists actively participating in the live surgery program, the department reaffirms its position as an international center of excellence. The fact that Professor Alexandre Mottrie, one of the pioneers of modern robotic urology, is one of the founders of the ERUS meeting adds a special dimension to AZORG’s presence in Padua.
urologygroupaalst.be
#UrologyGroupAalst #ERUS26 #RoboticSurgery #Urology
Edward Lambert retweeted
Proud to see Dr. D'Hondt and Dr. Lambert as invited speakers at the International Krupp Symposium.
Together with leading uro-oncology experts, they shared insights on robot-assisted radical cystectomy, aiming to improve outcomes and quality of life for bladder cancer patients.
Edward Lambert retweeted
Bladder Cancer Awareness Day 🎗️
Hematuria should never be ignored. Early evaluation saves lives.
At Urology Group Aalst, we offer 20+ years of expertise in minimally invasive bladder cancer care, with tailored treatments for every patient.
mdpi.com/2072-6694/17/18/306…
Edward Lambert retweeted
🔥 Tremendous week for Urology Group Aalst at AZORG 🔥
🥇First Belgian tele-proctoring RARP by Dr. Geert De Naeyer & Dr. Frederiek D'Hondt
🥇 First AI-supported RAPN by Prof. Dr. Alex Mottrie & Dr. Ir. Pieter De Backer
vrt.be/vrtnws/nl/kijk/2026/0…
Edward Lambert retweeted
In cisplatin-ineligible patients with muscle-invasive bladder cancer, enfortumab vedotin–pembrolizumab plus surgery led to better event-free survival (74.7%, vs. 39.4%) and overall survival (79.7%, vs. 63.1%) than surgery alone at 2 years. Full phase 3 KEYNOTE-905/EV-303 trial results: nej.md/4czl8sG
Editorial: Enfortumab Vedotin plus Pembrolizumab as Perioperative Therapy nej.md/4twnv5T
ALT The Kaplan–Meier estimates of event-free survival as assessed by blinded independent central review in the intention-to-treat population, which included all participants who had undergone randomization.
Edward Lambert retweeted
One month ago, Edward Lambert successfully defended his PhD thesis, focusing on optimizing outcomes for patients with localized or metastatic prostate cancer. This achievement reflects UGA's ongoing commitment to advancing knowledge and improving patient care.
Edward Lambert retweeted
Proud of our two colleagues Prof. Dr. Alex Mottrie and Dr. Ir. Pieter De Backer for their achievements as pioneers in AI driven surgery. The future of surgery is being built here! 🦾🩺
link.msgsndr.com/sp/e40fcd1e…
#DataDriven #ORSI #AI #Innovation #DeTijd #AalstUrologyGroup
Edward Lambert retweeted
Dr. Ir. Pieter De Backer has joined the Aalst Urology Group as the 13th member of the team. As a urologist and engineer, he is considered an international expert in innovation and AI-driven surgical support. He will mainly focus on surgical innovation and robot-assisted surgery.
Edward Lambert retweeted
@UAalst6631
Welcome to UGA – Urology Group Aalst! 🩺 13 superspecialised urologists • All subdisciplines • 6 campuses. 25y Robotics | 15y HOLEP | 8y REZUM | integrated uro-oncology. Pioneers in Aquablation, AI-assisted surgery & tele-surgery. 450+ pubs. TopCare. Forwardism.
Edward Lambert retweeted
I smile: when one contributes data that even minimally challenge the idea of #radiotherapy as uneventful, it is dismissed as “narrative”; yet in some RCTs (PACE-A), reporting 50% incontinence at 2 years after #prostatectomy is called “data”.
Edward Lambert retweeted
Congrats 🎊 @EdwLambert it was a huge step forward and your work on #prostate #cancer has really been appreciated we will remember it not only for the quality of your data but also for the weather conditions ❄️
Earlier this week, I successfully defended my PhD, marking the conclusion of a long and rigorous doctoral journey. Grateful to my promotors Charles Van Praet and Nicolaas Lumen, and to all jury members, for their guidance and critical insights. Looking ahead to new challenges!
Great day of sharing experience and insights on bladder cancer surgery. Honoured to be part of the expert panel discussion on advancing intracorporeal robotic neobladder surgery in Perugia 🇮🇹 🤖
Special thanks to Prof. @RoccoPapaliaUro
@AalstOlv @alexmottrie
🛜🥇🤖First teleproctoring case in Europe: Robot-assisted radical prostatectomy tele-surgery with two sugeons 600 kms apart as a live-case for the German Society for Robot-Assisted Urology #DRUS congress 🇩🇪.
@gdnaeyer @alexmottrie @MicroPort #Toumai
youtube.com/watch?v=XfhQRd6y…
pCR rate of 57% after NA EV+P in Cis ineligble BCa patients. How will we select those who can preserve their bladder?
Exciting data presented by @cvulsteke at #ESMO25 #bladdercancer
Edward Lambert retweeted
KN905
Very impressive results with neoadjuvant EV-P in cisplatin-ineligible muscle invasive #bladdercancer presented by C Vulsteke at #ESMO25
✅Improved PFS & OS
✅High path CR rates (57%)
✅No delay in surgery
✅Expected toxicity in this frail population
New SOC
Edward Lambert retweeted
1/2 KN905 Enfortumab Vedotin + Pembro continues to transform bladder cancer in spectacle fashion. In cisplatin ineligible operable disease it beats cystectomy with EFS HR 0.4, OS HR 0.5. pCR of 57% is much ⬆️ than anything before #ESMO25 pCR> 50% questions unselected surgery
🔥Very exciting talk on the future of advanced prostate cancer treatment by Gerhardt Attard & @UrsulaVogl at #ESMO25 #ProstateCancer
Edward Lambert retweeted
Check our latest article on #ERAS for radical cystectomy!!
HUGE effort from all the group
👏 @albisinnidoc & @andreamari08
@EAUYAUrology @Uroweb @eau_yuo
🚨 @EAU_YAUrotheli nailed another project! Glad to share our revision and expert consensus on #ERAS for patients undergoing Radical Cystectomy #bladdercancer @Uroweb @SIU_Italia @andreamari08 @agallioli @f_delgiudice @Mjaess @LAUrology_NL
sciencedirect.com/science/ar…